Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Procedural Sedation in TEE
NCT06129188Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of remimazolam in Anesthesia (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Blood pressure and Heart rate. Started Feb 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT06129188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06129188.